BDBM658027 1-(4-fluoro-2- methylphenyl)-3- (2-methyl-6-oxo- 1,6-dihydropyr- idin-3-yl)-7-(tri- fluoromethyl)- 2,3-dihydropyr- imido-[4,5-d]pyr- imidin-4(1H)-one::US20240083896, Example 2

SMILES Cc1cc(F)ccc1N1CN(C(=O)c2cnc(nc12)C(F)(F)F)c1ccc(=O)[nH]c1C

InChI Key InChIKey=NCHITRRMMTYOTK-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 658027   

TargetSodium channel protein type 5 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM658027(US20240083896, Example 2 | 1-(4-fluoro-2- methylph...)
Affinity DataIC50: 1.00E+3nMAssay Description:Pharmacological assessment of the compounds of the invention was performed using HEK293-Nav1.8 in combination with an assay developed on the QPatch 4...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent